Polbud Developsp. z o.o.

Realization of building projects related to erection of buildings

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-08-25
Share capital
500 000,00 PLN
Registered address
16, 64-310 Komorowo, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 217 days for 2023).

  • 2025not filed
  • 202417/07/2025
  • 202317/02/2025
  • 202227/10/2023
  • 202103/01/2023
  • 202011/12/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 25.08kMedianUSD 139.82kAverageUSD 1.44m
Net profit
This companyUSD -465.41MedianUSD 283.27AverageUSD 142.72k
Operating costs
This companyUSD 24.67kMedianUSD 105.89kAverageUSD 1.16m
Assets
This companyUSD 677.18kMedianUSD 497.07kAverageUSD 3.94m

Authorized Representatives

Jarosław Andrzej Grzywacz – President of the Management Board
Bartłomiej Kwilicz – Vice President of the Management Board

Manner of representation

In the case of a multi-member management board, the President of the Management Board jointly with one of the members of the management board or with a commercial proxy is authorized. In the case of a one-person management board, the President of the Management Board independently.

Ownership

OwnerSharesShare valueStake
Danuta Grzywaczage 74
2,500$67,531.0650%
Bartłomiej Kwiliczage 43
2,500$67,531.0650%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-09-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$4,486
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

FAQ

Last updated: 2026-04-24